A Strategic Framework for M&A Readiness for Biotech Management and Board
In the high-stakes world of biotechnology, an acquisition offer can redefine a company’s legacy in a matter of weeks. Dheeraj Chinthalapelly, Director of Healthcare Investment Banking at Truist Securities, outlines a definitive strategic framework for M&A readiness.



















